Seval Beykan

⁶⁸Ga- and ¹⁷⁷Lu-Labeled PSMA I&T: Optimization of a PSMA-Targeted Theranostic Concept and First Proof-of-Concept Human Studies

Martina Weineisen, Margret Schottelius, Jakub Šimeček et al. · Journal of Nuclear Medicine · 2015 · 532 citations · Full text

Medicine, Oncology, Pharmacology +17

Biodistribution and Radiation Dosimetry for a Probe Targeting Prostate-Specific Membrane Antigen for Imaging and Therapy

Ken Herrmann, Christina Bluemel, Martina Weineisen et al. · Journal of Nuclear Medicine · 2015 · 143 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

[¹⁷⁷Lu]pentixather: Comprehensive Preclinical Characterization of a First CXCR4-directed Endoradiotherapeutic Agent

Margret Schottelius, Theresa Osl, Andreas Poschenrieder et al. · Theranostics · 2017 · 132 citations · Full text

Medicine, Oncology, Pharmacology +17

Safety, Biodistribution, and Radiation Dosimetry of ⁶⁸Ga-OPS202 in Patients with Gastroenteropancreatic Neuroendocrine Tumors: A Prospective Phase I Imaging Study

Guillaume Nicolas, Seval Beykan, Hakim Bouterfa et al. · Journal of Nuclear Medicine · 2017 · 90 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Synthesis and preclinical evaluation of an Al18F radiofluorinated GLU-UREA-LYS(AHX)-HBED-CC PSMA ligand

Stefano Boschi, Jason T. Lee, Seval Beykan et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2016 · 52 citations · Full text

Pharmacy, Chemistry, Medicinal Chemistry +12